MedTrace Logo

Study to Evaluate the Use of Tilapia Skin (Oreochromis Niloticus), in the Treatment of Burn Wounds

NCT03592498 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2018-07-19

No results posted yet for this study

Summary

Randomised Clinical Study to evaluate the efficacy of Nile tilapia (Oreochromis niloticus) skin as an occlusive biological dressing, in the treatment of humans burn wounds.

Conditions

  • Burns

Interventions

DRUG

Sulfadiazine, Silver

Application of silver sulfadiazine ointment, bandage covered with gauze and bandage.

DEVICE

Skin of Nile tilapia

Application of skin of Nile tilapia (Oreochromis niloticus), as a biological occlusive dressing.

Sponsors & Collaborators

  • Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara

    lead OTHER

Principal Investigators

  • Maria Elisabete A Moraes, MD · Clinical Pharmacology Unit, Drug Research and Development Center, Federal University of Ceara (UFC)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-05
Primary Completion
2017-09-20
Completion
2017-09-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03592498 on ClinicalTrials.gov